*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Apretude 600 mg Prolonged-release Suspension for Injection

Cabotegravir
600 mg
Suspension for injection

ROA

Intramuscular

Applicant Name

GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)

NRN

A4-100537

Status

Active


ATC Code

J05AJ04  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1vial,1vialx25  

Product Description

31 NF-PP-335639 Apretude 600 mg Prolonged-release Suspension for Injection Cabotegravir Cabotegravir 600 mg, Mannitol (E421) Polysorbate 20 (E432) Macrogol (E1521) Water for injections Drugs Imported Products 1vial,1vial*25 Prescription Only Medicine (POM) 6/22/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations) , Harmire Road Barnard Castle Co. Durham DL12 8DT United Kingdom, United Kingdom

Manufacturer Name

Glaxo Operations UK Limited

Manufacturer Country

UNITED KINGDOM  

Approval Date

2023-09-28  

Expiry Date

2028-09-27